Statement by cassava sciences regarding an internal cuny report leaked to the press

Austin, texas, oct. 12, 2023 (globe newswire) -- cassava sciences, inc. (nasdaq: sava), a clinical-stage biotechnology company focused on alzheimer's disease, today issued the following statement regarding an internal report purportedly prepared by city university of new york (cuny). this report was leaked to the press. the leak of the cuny report was preceded by a 40% increase in short selling activity in the stock of cassava sciences.
SAVA Ratings Summary
SAVA Quant Ranking